BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 23830962)

  • 1. Conservative management of bisphosphonate-related osteonecrosis of the jaws: staging and treatment outcomes.
    Lerman MA; Xie W; Treister NS; Richardson PG; Weller EA; Woo SB
    Oral Oncol; 2013 Sep; 49(9):977-983. PubMed ID: 23830962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisphosphonate-related osteonecrosis of the jaws: Report of a case using conservative protocol.
    Heggendorn FL; Leite TC; Cunha KS; Junior AS; Gonçalves LS; da Costa KB; Dias EP
    Spec Care Dentist; 2016 Jan; 36(1):43-7. PubMed ID: 26782365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience with the treatment of bisphosphonate-related osteonecrosis of the jaw.
    Janovska Z; Mottl R; Slezak R
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Jun; 159(2):313-7. PubMed ID: 24108250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical management of bisphosphonate-related osteonecrosis of the jaws: literature review.
    Silva LF; Curra C; Munerato MS; Deantoni CC; Matsumoto MA; Cardoso CL; Curi MM
    Oral Maxillofac Surg; 2016 Mar; 20(1):9-17. PubMed ID: 26659615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteonecrosis of the jaws associated with the use of bisphosphonates. Discussion over 52 cases.
    Almăşan HA; Băciuţ M; Rotaru H; Bran S; Almăşan OC; Băciuţ G
    Rom J Morphol Embryol; 2011; 52(4):1233-41. PubMed ID: 22203928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The outcomes of conservative and surgical treatment of stage 2 bisphosphonate-related osteonecrosis of the jaws: a case series.
    Jabbour Z; El-Hakim M; Mesbah-Ardakani P; Henderson JE; Albuquerque R
    Int J Oral Maxillofac Surg; 2012 Nov; 41(11):1404-9. PubMed ID: 22704590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dental implications of bisphophonate-related osteonecrosis.
    Saldanha S; Shenoy VK; Eachampati P; Uppal N
    Gerodontology; 2012 Sep; 29(3):177-87. PubMed ID: 22486711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for medication-related osteonecrosis of the jaw and salivary IL-6 IN cancer patients.
    Kemp APT; Ferreira VHC; Mobile RZ; Brandão TB; Sassi LM; Zarpellon A; Braz-Silva PH; Schussel JL
    Braz J Otorhinolaryngol; 2022; 88(5):683-690. PubMed ID: 33189595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing surgical treatment of bisphosphonate-related osteonecrosis of the jaws.
    Wutzl A; Pohl S; Sulzbacher I; Seemann R; Lauer G; Ewers R; Drach J; Klug C
    Head Neck; 2012 Feb; 34(2):194-200. PubMed ID: 21400630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating low- and medium-potency bisphosphonate-related osteonecrosis of the jaws with a protocol for the treatment of chronic suppurative osteomyelitis: report of 7 cases.
    Alons K; Kuijpers SC; de Jong E; van Merkesteyn JP
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Feb; 107(2):e1-7. PubMed ID: 19071040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical treatment outcomes for 40 patients with bisphosphonates-related osteonecrosis of the jaws.
    Lee LW; Hsiao SH; Chen LK
    J Formos Med Assoc; 2014 Mar; 113(3):166-72. PubMed ID: 24630034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonate-associated osteonecrosis of the jaws -- report of three cases in Bulgaria and review of the literature.
    Pechalova P; Bakardjiev A; Zaprianov Z; Vladimirov B; Poriazova E; Zheleva A; Hadjigeorgiev G; Goranova-Marinova V; Goranov S
    Acta Clin Croat; 2011 Jun; 50(2):273-9. PubMed ID: 22263396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonate-related osteonecrosis of the jaws: Cohort study of surgical treatment results in seventy-four stage II/III patients.
    Pichardo SE; Kuijpers SC; van Merkesteyn JP
    J Craniomaxillofac Surg; 2016 Sep; 44(9):1216-20. PubMed ID: 27421170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survey of Korean dentists on the awareness on bisphosphonate-related osteonecrosis of the jaws.
    Yoo JY; Park YD; Kwon YD; Kim DY; Ohe JY
    J Investig Clin Dent; 2010 Nov; 1(2):90-5. PubMed ID: 25427263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonate-induced avascular osteonecrosis of the jaws: a clinical report of 11 cases.
    Dimitrakopoulos I; Magopoulos C; Karakasis D
    Int J Oral Maxillofac Surg; 2006 Jul; 35(7):588-93. PubMed ID: 16687238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical treatment of bisphosphonate-associated osteonecrosis of the jaw: technical report and follow up of 21 patients.
    Voss PJ; Joshi Oshero J; Kovalova-Müller A; Veigel Merino EA; Sauerbier S; Al-Jamali J; Lemound J; Metzger MC; Schmelzeisen R
    J Craniomaxillofac Surg; 2012 Dec; 40(8):719-25. PubMed ID: 22336489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic cancer identified in osteonecrosis specimens of the jaws in patients receiving intravenous bisphosphonate medications.
    Carlson ER; Fleisher KE; Ruggiero SL
    J Oral Maxillofac Surg; 2013 Dec; 71(12):2077-86. PubMed ID: 23945512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonate-related osteonecrosis of the jaws. A severe side effect of bisphosphonate therapy.
    Janovská Z
    Acta Medica (Hradec Kralove); 2012; 55(3):111-5. PubMed ID: 23297518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphosphonate-related osteonecrosis of the jaws--a case report.
    Kamoh AK; Ogle O
    Compend Contin Educ Dent; 2012 May; 33(5):e74-7. PubMed ID: 23268588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bisphosphonate-related osteonecrosis of the jaw].
    Atanes-Bonome P; Atanes-Bonome A; Ríos-Lage P; Atanes-Sandoval AD
    Semergen; 2014 Apr; 40(3):143-8. PubMed ID: 24001573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.